These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 6726057)

  • 1. Plasma levels of salicylate and aspirin in healthy volunteers: relevance to drug interaction on platelet function.
    Cerletti C; Bonati M; del Maschio A; Galletti F; Dejana E; Tognoni G; de Gaetano G
    J Lab Clin Med; 1984 Jun; 103(6):869-77. PubMed ID: 6726057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma".
    Cerletti C; Latini R; Del Maschio A; Galletti F; Dejana E; de Gaetano G
    Thromb Haemost; 1985 Jun; 53(3):415-8. PubMed ID: 4049312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
    Rosenkranz B; Fischer C; Meese CO; Frölich JC
    Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose aspirin in pregnancy.
    Sibai BM; Mirro R; Chesney CM; Leffler C
    Obstet Gynecol; 1989 Oct; 74(4):551-7. PubMed ID: 2797631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
    de Gaetano G; Cerletti C; Dejana E; Latini R
    Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
    FitzGerald GA; Lupinetti M; Charman SA; Charman WN
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1043-9. PubMed ID: 1762060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M; Jilma B; Hergovich N; Stohlawetz P; Panzer S; Speiser W
    Thromb Haemost; 2000 Feb; 83(2):316-21. PubMed ID: 10739392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences.
    Anzellotti P; Capone ML; Jeyam A; Tacconelli S; Bruno A; Tontodonati P; Di Francesco L; Grossi L; Renda G; Merciaro G; Di Gregorio P; Price TS; Garcia Rodriguez LA; Patrignani P
    Arthritis Rheum; 2011 Mar; 63(3):850-9. PubMed ID: 21360514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pharmacology of naproxen sodium.
    Capone ML; Tacconelli S; Sciulli MG; Anzellotti P; Di Francesco L; Merciaro G; Di Gregorio P; Patrignani P
    J Pharmacol Exp Ther; 2007 Aug; 322(2):453-60. PubMed ID: 17473175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium salicylate interferes with the inhibitory effects of aspirin and indomethacin on human platelets.
    Dahl ML; Puustinen T; Uotila P
    Prostaglandins Leukot Med; 1983 Sep; 12(1):21-8. PubMed ID: 6415666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
    Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
    J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
    Pedersen AK; FitzGerald GA
    N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombocyte function of healthy probands taking 50 mg of acetylsalicylic acid per day].
    Sinzinger H; Kritz H; Pirich C; Karanikas G; Kurtaran A; Banyai M; Peskar BA; Rehak P
    Wien Klin Wochenschr; 1995; 107(15):457-63. PubMed ID: 7676685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.